Advances and applications of oral cancer basic research

Oral Oncology

Volumn 47, Issue 9, 2011, Pages 783-791

  Silva, Sabrina Daniela Da ^a,b   Ferlito, Alfio ^c   Takes, Robert P ^d   Brakenhoff, Ruud H ^e   Valentin, Mev Dominguez ^f   Woolgar, Julia A ^g   Bradford, Carol R ^h   Rodrigo, Juan P ⁱ   Rinaldo, Alessandra ^c   Hier, Michael P ^a   Kowalski, Luiz P ^b,j  

^a MCGILL UNIVERSITY   (Canada)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c UNIVERSITY OF UDINE   (Italy)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f LUND UNIVERSITY   (Sweden)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁱ HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^j DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

more..

Author keywords

Advances and applications; Cancer research; Molecular biology; Oral cancer; Squamous cell carcinoma

Indexed keywords

ADVANCED CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RESEARCH; CANCER STAGING; CARCINOGENESIS; EXPOSURE; GENETIC RISK; HUMAN; MORBIDITY; MOUTH CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; TUMOR GROWTH;

CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC TECHNIQUES AND PROCEDURES; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MEDICAL ONCOLOGY; MOUTH NEOPLASMS; NEOPLASTIC STEM CELLS; ONCOGENES; PROGNOSIS; RESEARCH; TUMOR MARKERS, BIOLOGICAL;

EID: 80052268545     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.07.004     Document Type: Review

References (157)

1. M. de Camargo Cancela, L. Voti, M. Guerra-Yi, F. Chapuis, M. Mazuir, and M.P. Curado Oral cavity cancer in developed and in developing countries: population-based incidence Head Neck 32 2010 357 367
2. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence. Mortality and prevalence worldwide. IARC CancerBase No 5, Lyon: IARC Press; 2004.
3. J.S. Cooper, K. Porter, and K. Mallin National Cancer Database report on cancer of the head and neck: 10-year update Head Neck 31 2009 748 758
4. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2008 CA Cancer J Clin 58 2008 71 96 (Pubitemid 351521864)
5. S.K. Knauer Prognostic and therapeutic potential of nuclear receptors in head and neck squamous cell carcinomas J Oncol 2009 2009 349205
6. L.P. Kowalski, J. Magrin, M. Sabóia, J.C. Santos, and H. Torloni Squamous cell carcinoma of the tongue: a review of 629 patients treated at a single institution South Am J Cancer 1 1997 245 254
7. L.P. Kowalski, A.L. Carvalho, A.V. Martins Priante, and J. Magrin Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma Oral Oncol 41 2005 534 541 (Pubitemid 40692856)
8. Brazilian Ministry of Health: http://www.portal.saude.gov.br/portal/ saude/August-2010.
9. M.D. Williams Integration of biomarkers including molecular targeted therapies in head and neck cancer Head Neck Pathol 4 2010 62 69
10. M. Hashibe, P. Brennan, and S.C. Chuang Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium Cancer Epidemiol Biomarkers Prev 18 2009 541 550
11. P.T. Hennessey, W.H. Westra, and J.A. Califano Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications J Dent Res 88 2009 300 306
12. D.I. Conway, L.M. Macpherson, J. Gibson, and V.I. Binnie Oral cancer: prevention and detection in primary dental healthcare Prim Dent Care 9 2002 119 123
13. B.R. Das, and J.K. Nagpal Understanding the biology of oral cancer Med Sci Monit 8 2002 RA258 RA267
14. A.M. Velly, E.L. Franco, and N. Schlecht Relationship between dental factors and risk of upper aerodigestive tract cancer Oral Oncol 34 1998 284 291 (Pubitemid 28318255)
15. L. Barnes, J.W. Eveson, P. Reichart, and D. Sidransky World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours 2005 IARC Press Lyon p. 430
16. R. Poveda-Roda, J.V. Bagán, Y. Jiménez-Soriano, M. Margaix-Muñoz, and M.G. Sarrión-Pérez Changes in smoking habit among patients with a history of oral squamous cell carcinoma (OSCC) Med Oral Patol Oral Cir Bucal 15 2010 e721 e726
17. Y. Nozad-Mojaver, M. Mirzaee, and A. Jafarzadeh Synergistic effects of cigarette smoke and saliva Med Oral Patol Oral Cir Bucal 14 2009 E217 E221
18. Javed F, Correa FO, Chotai M, Tappuni AR, Almas K. Systemic conditions associated with areca nut usage: a literature review. Scand J Public Health 2010 Aug 6. [Epub ahead of print].
19. S.J. Bhat, M.D. Blank, R.L. Balster, M. Nichter, and M. Nichter Areca nut dependence among chewers in a South Indian community who do not also use tobacco Addiction 105 2010 1303 1310
20. K.V. Rankin, D.L. Jones, and E. Benton Smokeless tobacco: challenges, products, and cessation Tex Dent J 127 2010 589 594
21. M.J. McCullough, and C.S. Farah The role of alcohol in oral carcinogenesis with particular reference to alcohol-containing mouthwashes Aust Dent J 53 2008 302 305
22. P.K. Tsantoulis, N.G. Kastrinakis, A.D. Tourvas, G. Laskaris, and V.G. Gorgoulis Advances in the biology of oral cancer Oral Oncol 43 2007 523 534 (Pubitemid 46860349)
23. H.K. Seitz, and F. Stickel Molecular mechanisms of alcohol-mediated carcinogenesis Nat Rev Cancer 7 2007 599 612 (Pubitemid 47106631)
24. J.A. Brennan, J.O. Boyle, and W.M. Koch Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck N Engl J Med 332 1995 712 717
25. R. Herrero, X. Castellsagué, and M. Pawlita Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study J Natl Cancer Inst 95 2003 1772 1783 (Pubitemid 38008900)
26. B.J. Braakhuis, P.J. Snijders, and W.J. Keune Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus J Natl Cancer Inst 96 2004 998 1006 (Pubitemid 39162642)
27. A.K. Chaturvedi, E.A. Engels, W.F. Anderson, and M.L. Gillison Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States J Clin Oncol 26 1 2008 612 619 (Pubitemid 351264356)
28. V. Mehta, G.P. Yu, and S.P. Schantz Population-based analysis of oral and oropharyngeal carcinoma: changing trends of histopathologic differentiation, survival and patient demographics Laryngoscope 120 2010 2203 2212
29. E. Negri, P. Boffetta, and J. Berthiller Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium Int J Cancer 124 2009 394 401
30. E. Kaminagakura, J.G. Vartanian, S.D. da Silva, C.R. Dos Santos, and L.P. Kowalski Case control study on prognostic factors in oral squamous cell carcinoma in young patients Head Neck 32 2010 1460 1466
31. W. Garavello, R. Foschi, and R. Talamini Family history and the risk of oral and pharyngeal cancer Int J Cancer 122 2008 1827 1831 (Pubitemid 351413430)
32. M. Ingelman-Sundberg Genetic variability in susceptibility and response to toxicants Toxicol Lett 120 2001 259 268 (Pubitemid 32375092)
33. J. Cloos, M.R. Spitz, and S.P. Schantz Genetic susceptibility to head and neck squamous cell carcinoma J Natl Cancer Inst 88 1996 530 535 (Pubitemid 26118723)
34. B.S. Shastry SNP alleles in human disease and evolution J Hum Genet 47 2002 561 566 (Pubitemid 36083255)
35. M. Gajecka, M. Rydzanicz, R. Jaskula-Sztul, M. Kujawski, W. Szyfter, and K. Szyfter CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma Mutat Res 574 2005 112 123 (Pubitemid 40725973)
36. A.F. Olshan, M.C. Weissler, M.A. Watson, and D.A. Bell GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer Cancer Epidemiol Biomarkers Prev 9 2000 185 191 (Pubitemid 30111942)
37. Y. Zheng, H. Shen, and E.M. Sturgis Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study Carcinogenesis 22 2001 1195 1199 (Pubitemid 32737335)
38. M. Huang, M.R. Spitz, and J. Gu Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions Carcinogenesis 27 2006 2034 2037 (Pubitemid 44530578)
39. Lacko M, Roelofs HM, Te Morsche RH, Voogd AC, Oude Ophuis MB, Peters WH, Manni JJ. Int J Cancer. 2010 Mar 3. [Epub ahead of print].
40. M. Lacko, H.M. Roelofs, R.H. te Morsche, A.C. Voogd, M.B. Ophuis, and W.H. Peters Head Neck 31 2009 1274 1281
41. R. Ankathil, A. Mathew, F. Joseph, and M.K. Nair Is oral cancer susceptibility inherited? Report of five oral cancer families Eur J Cancer B Oral Oncol 32B 1996 63 67
42. K.K. Yu, A.M. Zanation, J.R. Moss, and W.G. Yarbrough Familial head and neck cancer: molecular analysis of a new clinical entity Laryngoscope 112 2002 1587 1593 (Pubitemid 34977559)
43. J.P. de Winter, and H. Joenje The genetic and molecular basis of Fanconi anemia Mutat Res 668 2009 11 19
44. D.I. Kutler, A.D. Auerbach, and J. Satagopan High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia Arch Otolaryngol Head Neck Surg 129 2003 106 112 (Pubitemid 36070885)
45. P.S. Rosenberg, G. Socié, B.P. Alter, and E. Gluckman Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants Blood 105 2005 67 73 (Pubitemid 40053065)
46. J.D. McKay, T. Truong, and V. Gaborieau A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium PLoS Genet 7 3 2011 1001333 [Epub 2011 Mar 17]
47. J. Campo-Trapero, J. Cano-Sánchez, B. Palacios-Sánchez, J.J. Sánchez-Gutierrez, M.A. González-Moles, and A. Bascones-Martínez Update on molecular pathology in oral cancer and precancer Anticancer Res 28 2008 1197 1205 (Pubitemid 351578858)
48. J. Califano, W.H. Westra, G. Meininger, R. Corio, W.M. Koch, and D. Sidransky Genetic progression and clonal relationship of recurrent premalignant head and neck lesions Clin Cancer Res 6 2000 347 352 (Pubitemid 30111449)
49. J. Califano, P. van der Riet, and W. Westra Genetic progression model for head and neck cancer: implications for field cancerization Cancer Res 56 1996 2488 2492 (Pubitemid 26170679)
50. Theocharis S, Klijanienko J, Giaginis C, et al. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival. J Oral Pathol Med 2010 Oct 1. [Epub ahead of print].
51. C.Y. Yen, S.Y. Liu, and C.H. Chen Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan J Oral Pathol Med 37 2008 271 277
52. H. Görgens, A. Müller, and S. Krüger Analysis of the base excision repair genes MTH1, OGG1 and MUTYH in patients with squamous oral carcinomas Oral Oncol 43 2007 791 795 (Pubitemid 47259445)
53. M.J. Rodríguez, A. Acha, M.T. Ruesga, C. Rodríguez, J.M. Rivera, and J.M. Aguirre Loss of expression of DNA repair enzyme MGMT in oral leukoplakia and early oral squamous cell carcinoma. A prognostic tool? Cancer Lett 245 2007 263 268 (Pubitemid 44959359)
54. T. Sugimura, H. Kumimoto, and I. Tohnai Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms J Oral Pathol Med 35 2006 11 18
55. C. Scully, J.K. Field, and H. Tanzawa Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1 carcinogen metabolism, DNA repair and cell cycle control Oral Oncol 36 2000 256 263 (Pubitemid 30227706)
56. E.M. Sturgis, E.J. Castillo, and L. Li Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck Carcinogenesis 20 1999 2125 2129 (Pubitemid 29535314)
57. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70 (Pubitemid 30046295)
58. H.K. Williams Molecular pathogenesis of oral squamous carcinoma Mol Pathol 53 2000 165 172 (Pubitemid 30603069)
59. C.h.R. Leemans, B.J.M. Braakhuis, and R.H. Brakenhoff Molecular biology of head and neck cancer Nat Rev Cancer 11 2011 9 22
60. T.R. Geiger, and D.S. Peeper Metastasis mechanisms Biochim Biophys Acta 1796 2009 293 308
61. W.K. Mydlarz, P.T. Hennessey, and J.A. Califano Advances and perspectives in the molecular diagnosis of head and neck cancer Expert Opin Med Diagn 4 2010 53 65
62. S.K. Mithani, W.K. Mydlarz, F.L. Grumbine, I.M. Smith, and J.A. Califano Molecular genetics of premalignant oral lesions Oral Dis 13 2007 126 133
63. C.L. Martin, S.C. Reshmi, and T. Ried Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature Oral Oncol 44 2008 369 382 (Pubitemid 351380982)
64. Graveland AP, Golusinski PJ, Buijze M, et al. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma. Int J Cancer 2010 Jun 21. [Epub ahead of print].
65. A. Ghosh, S. Ghosh, and G.P. Maiti Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance Cancer Sci 101 2010 1511 1520
66. K. Freier, K. Knoepfle, and C. Flechtenmacher Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma Genes Chromosomes Cancer 49 2010 9 16
67. E. Allegra, F. Baudi, A. La Boria, F. Fagiani, A. Garozzo, and F.S. Costanzo Multiple head and neck tumours and their genetic relationship Acta Otorhinolaryngol Ital 29 2009 237 241
68. S. Ghosh, A. Ghosh, and G.P. Maiti Alterations of ROBO1/DUTT1 and ROBO2 loci in early dysplastic lesions of head and neck: clinical and prognostic implications Hum Genet 125 2009 189 198
69. E. Roman, L.A. Meza-Zepeda, S.H. Kresse, O. Myklebost, E.N. Vasstrand, and S.O. Ibrahim Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization Oncol Rep 20 2008 825 843
70. S. Ghosh, A. Ghosh, and G.P. Maiti Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: correlation with progression and prognosis Int J Cancer 123 2008 2594 2604
71. S. Koy, J. Plaschke, and H. Luksch Microsatellite instability and loss of heterozygosity in squamous cell carcinoma of the head and neck Head Neck 30 2008 1105 1113
72. L. Mao, J.S. Lee, and Y.H. Fan Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment Nat Med 2 1996 682 685 (Pubitemid 26191956)
73. G. Thomas, M. Hashibe, and B.J. Jacob Risk factors for multiple oral premalignant lesions Int J Cancer 107 2003 285 291 (Pubitemid 37152912)
74. D.P. Slaughter, H.W. Southwick, and W. Smejkal Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 6 1953 963 968
75. M.P. Tabor, R.H. Brakenhoff, and V.M. van Houten Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications Clin Cancer Res 7 2001 1523 1532 (Pubitemid 32708615)
76. B. Perez-Ordoñez, M. Beauchemin, and R.C. Jordan Molecular biology of squamous cell carcinoma of the head and neck J Clin Pathol 59 2006 445 453
77. G.C. Bedi, W.H. Westra, E. Gabrielson, W. Koch, and D. Sidransky Multiple head and neck tumors: evidence for a common clonal origin Cancer Res 56 1996 2484 2487 (Pubitemid 26170678)
78. M.P. Tabor, R.H. Brakenhoff, and H.J. Ruijter-Schippers Multiple head and neck tumors frequently originate from a single preneoplastic lesion Am J Pathol 161 2002 1051 1060 (Pubitemid 34988393)
79. M.P. Tabor, R.H. Brakenhoff, H.J. Ruijter-Schippers, J.A. Kummer, C.R. Leemans, and B.J. Braakhuis Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study Clin Cancer Res 10 2004 3607 3613 (Pubitemid 38697593)
80. J.G. Vartanian, A.L. Carvalho, M.J. de Araújo Filho, M.H. Junior, J. Magrin, and L.P. Kowalski Predictive factors and distribution of lymph node metastasis in lip cancer patients and their implications on the treatment of the neck Oral Oncol 40 2004 223 227 (Pubitemid 38030368)
81. T.M. Pimenta Amaral, A.R. Da Silva Freire, A.L. Carvalho, C.A. Pinto, and L.P. Kowalski Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth Oral Oncol 40 2000 780 786 (Pubitemid 39061092)
82. R.P. Takes, A. Rinaldo, J.P. Rodrigo, K.O. Devaney, J.J. Fagan, and A. Ferlito Can biomarkers play a role in the decision about treatment of the clinically negative neck in patients with head and neck cancer? Head Neck 30 2008 525 538 (Pubitemid 351578758)
83. P. Roepman, L.F. Wessels, and N. Kettelarij An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas Nat Genet 37 2005 182 186
84. S. Ramaswamy, K.N. Ross, E.S. Lander, and T.R. Golub A molecular signature of metastasis in primary solid tumors Nat Genet 33 2003 49 54 (Pubitemid 36068681)
85. M. Okura, T. Aikawa, N.Y. Sawai, S. Iida, and M. Kogo Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma Oral Oncol 45 2009 908 911
86. F.J. Civantos, S.J. Stoeckli, and R.P. Takes What is the role of sentinel lymph node biopsy in the management of oral cancer in 2010? Eur Arch Otorhinolaryngol 267 2010 839 844
87. R.L. Ferris, L. Xi, R.R. Seethala, J. Chan, S. Desai, and B. Hoch Intraoperative qRT-PCR for detection of lymph node metastasis in head and neck cancer Clin Cancer Res 17 2011 1858 1866 [Epub 2011 Feb 25]
88. J.Z. Xu, and C.W. Wong Hunting for robust gene signature from cancer profiling data: sources of variability, different interpretations, and recent methodological developments Cancer Lett 296 2010 9 16
89. Q. Wei, L. Sheng, Y. Shui, Q. Hu, H. Nordgren, and J. Carlsson EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases Ann Surg Oncol 15 2008 1193 1201
90. H. Zhang, A. Berezov, and Q. Wang ErbB receptors: from oncogenes to targeted cancer therapies J Clin Invest 117 2007 2051 2058 (Pubitemid 47224766)
91. R. Roskoski Jr The ErbB/HER receptor protein-tyrosine kinases and cancer Biochem Biophys Res Commun 319 2004 1 11 (Pubitemid 38670153)
92. P. Casalini, M.V. Iorio, E. Galmozzi, and S. Ménard Role of HER receptors family in development and differentiation J Cell Physiol 200 2004 343 350 (Pubitemid 39006925)
93. S.D. Silva, I.W. Cunha, R.N. Younes, F.A. Soares, L.P. Kowalski, and E. Graner ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas Oral Dis 16 2010 774 780
94. S.D. Silva, I.W. Cunha, and I.N. Nishimoto Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas Oral Oncol 45 2009 e134 e139
95. K.N. Syrigos, A. Zalonis, E. Kotteas, and M.W. Saif Targeted therapy for oesophageal cancer: an overview Cancer Metastasis Rev 27 2008 273 288
96. S.D. Silva, I.W. Cunha, and A.L. Rangel Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes Virchows Arch 453 2008 57 67
97. S.D. Silva, M. Agostini, and I.N. Nishimoto Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study Oral Oncol 40 2004 688 696 (Pubitemid 38686905)
98. P. O-charoenrat, P.H. Rhys-Evans, H. Modjtahedi, and S.A. Eccles The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma Oral Oncol 38 2002 627 640 (Pubitemid 34880101)
99. T. Zeren, S. Inan, H. Seda Vatansever, N. Ekerbicer, and S. Sayhan Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha Acta Histochem 110 2008 256 263 (Pubitemid 351626123)
100. L.G. Marcu, and E. Yeoh A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment J Cancer Res Clin Oncol 135 2009 1303 1314
101. J.J. Sheu, C.H. Hua, and L. Wan Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma Cancer Res 69 2009 2568 2576
102. S.M. Bentzen, B.M. Atasoy, and F.M. Daley Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial J Clin Oncol 23 2005 5560 5567
103. J.A. Bonner, P.M. Harari, J. Giralt, N. Azarnia, D.M. Shin, and R.B. Cohen Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 9 2006 567 578 (Pubitemid 43209104)
104. R. Agarwal, M. Carey, B. Hennessy, and G.B. Mills PI3K pathway-directed therapeutic strategies in cancer Curr Opin Investig Drugs 11 2010 615 628
105. N.T. Ihle, and G. Powis Inhibitors of phosphatidylinositol-3-kinase in cancer therapy Mol Aspects Med 31 2010 135 144
106. M. Falasca PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs Curr Pharm Des 16 2010 1410 1416
107. K.D. Courtney, R.B. Corcoran, and J.A. Engelman The PI3K pathway as drug target in human cancer J Clin Oncol 28 2010 1075 1083
108. K.K. Wong, J.A. Engelman, and L.C. Cantley Targeting the PI3K signaling pathway in cancer Curr Opin Genet Dev 20 2010 87 90
109. N. Barker The canonical WNT/beta-catenin signalling pathway Methods Mol Biol 468 2008 5 15
110. S. Tommasi, R. Pinto, B. Pilato, and A. Paradiso Molecular pathways and related target therapies in liver carcinoma Curr Pharm Des 13 2007 3279 3287 (Pubitemid 350201682)
111. L. Larue, and A. Bellacosa Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways Oncogene 24 2005 7443 7454 (Pubitemid 41637984)
112. A. Nawshad, D. Lagamba, A. Polad, and E.D. Hay Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis Cells Tissues Organs 179 2005 11 23 (Pubitemid 40976285)
113. W.J. Nelson, and R. Nusse Convergence of WNT β-catenin, and cadherin pathways Science 303 2004 1483 1487 (Pubitemid 38314410)
114. M. Conacci-Sorrell, J. Zhurinsky, and A. Ben-Ze'ev The cadherin-catenin adhesion system in signaling and cancer J Clin Invest 109 2002 987 991 (Pubitemid 34408571)
115. B. Boyer, A.M. Valles, and N. Edme Induction and regulation of epithelial-mesenchymal transitions Biochem Pharmacol 60 2000 1091 1099
116. N. Bhattacharya, A. Roy, B. Roy, S. Roychoudhury, and C.K. Panda MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients J Oral Pathol Med 38 2009 759 763
117. K. Myo, N. Uzawa, R. Miyamoto, I. Sonoda, Y. Yuki, and T. Amagasa Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM stage I and II squamous cell carcinoma of the oral cavity Cancer 104 2005 2709 2716 (Pubitemid 41798281)
118. R. Miyamoto, N. Uzawa, S. Nagaoka, Y. Hirata, and T. Amagasa Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas Oral Oncol 39 2003 610 618 (Pubitemid 36694486)
119. A. Rousseau, M.S. Lim, Z. Lin, and R.C. Jordan Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias Oral Oncol 37 2001 268 275 (Pubitemid 32245851)
120. B. Khademi, F.M. Shirazi, and M. Vasei The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors Cancer Lett 184 2002 223 230 (Pubitemid 34804508)
121. R. Hrstka, P.J. Coates, and B. Vojtesek Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment J Cell Mol Med 13 2009 440 453
122. R.K. Thomas, A.C. Baker, and R.M. DeBiasi High-throughput oncogene mutation profiling in human cancer Nat Genet 39 2007 347 351 (Pubitemid 46328493)
123. M.E. Prince, R. Sivanandan, and A. Kaczorowski Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proc Natl Acad Sci USA 104 2007 973 978 (Pubitemid 46154721)
124. J.M. García Bueno, A. Ocaña, and P. Castro-García An update on the biology of cancer stem cells in breast cancer Clin Transl Oncol 10 2008 786 793
125. Y.W. Chen, K.H. Chen, and P.I. Huang Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma-derived CD44+ALDH1+ cells Mol Cancer Ther 9 2010 2879 2892
126. M.R. Clay, M. Tabor, and J.H. Owen Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase Head Neck 32 2010 1195 1201
127. Albers AE, Chen C, Köberle B, Qian X, Klussmann JP, Wollenberg B, Kaufmann AM.Stem cells in squamous head and neck cancer. Crit Rev Oncol Hematol. 2011 Apr 19. [Epub ahead of print].
128. S. Gandolfo, M. Pentenero, R. Broccoletti, M. Pagano, M. Carrozzo, and C. Scully Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment Oral Oncol 42 2006 89 95 (Pubitemid 41831528)
129. J.B. Epstein, R. Feldman, R.J. Dolor, and S.R. Porter The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer Head Neck 25 2003 911 921 (Pubitemid 37323006)
130. M.A. Onofre, M.R. Sposto, and C.M. Navarro Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 2001 535 540 (Pubitemid 33601661)
131. I.C. Martin, C.J. Kerawala, and M. Reed The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 1998 444 446 (Pubitemid 128645222)
132. K.A. Warnakulasuriya, and N.W. Johnson Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer J Oral Pathol Med 25 1996 97 103 (Pubitemid 126673996)
133. A. Mashberg Final evaluation of tolonium chloride rinse for screening of high-risk patients with asymptomatic squamous carcinoma J Am Dent Assoc 106 1983 319 323
134. J.A. Kiernan Histological and Histochemical Methods: Theory and Practice 1999 Arnold London
135. S. Fedele Diagnostic aids in the screening of oral cancer Head Neck Oncol 1 2009 5
136. M.W. Lingen, J.R. Kalmar, T. Karrison, and P.M. Speight Critical evaluation of diagnostic aids for the detection of oral cancer Oral Oncol 44 2008 10 22 (Pubitemid 350258631)
137. M.A. Huber, S.A. Bsoul, and G.T. Terezhalmy Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study Quintessence Int 35 2004 378 384 (Pubitemid 38515509)
138. N.M. Lonky, W.J. Mann, and L.S. Massad Ability of visual tests to predict underlying cervical neoplasia. Colposcopy and speculoscopy J Reprod Med 40 1995 530 536
139. C.S. Farah, and M.J. McCullough A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions Oral Oncol 43 2007 820 824 (Pubitemid 47259448)
140. L.L. Patton, J.B. Epstein, and A.R. Kerr Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature J Am Dent Assoc 139 2008 896 905
141. B. Swinson, W. Jerjes, M. El-Maaytah, P. Norris, and C. Hopper Optical techniques in diagnosis of head and neck malignancy Oral Oncol 42 2006 221 228 (Pubitemid 43246754)
142. C. Piazza, D. Cocco, and F. Del Bon Narrow band imaging and high definition television in evaluation of oral and oropharyngeal squamous cell cancer: a prospective study Oral Oncol 46 2010 307 310
143. Keereweer S, Sterenborg HJ, Kerrebijn JD, Van Driel PB, de Jong RJ, Löwik CW. Image-guided surgery in head and neck cancer: Current practice and future directions of optical imaging. Head Neck. 2011 Jan 31. [Epub ahead of print].
144. C.T. Viet, and B.L. Schmidt Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients Cancer Epidemiol Biomarkers Prev 17 2008 3603 3611
145. S. Hu, M. Arellano, and P. Boontheung Salivary proteomics for oral cancer biomarker discovery Clin Cancer Res 14 2008 6246 6252
146. R. Radpour, Z. Barekati, C. Kohler, W. Holzgreve, and X.Y. Zhong New trends in molecular biomarker discovery for breast cancer Genet Test Mol Biomarkers 13 2009 565 571
147. S. Fleskens, and P. Slootweg Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility Head Neck Oncol 1 2009 11
148. S.J. Fleskens, R.P. Takes, and I. Otte-Höller Simultaneous assessment of DNA ploidy and biomarker expression in paraffin-embedded tissue sections Histopathology 57 2010 14 26
149. A. Torres-Rendon, R. Stewart, G.T. Craig, M. Wells, and P.M. Speight DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression Oral Oncol 45 2009 468 473
150. V.E. Bergshoeff, A.H. Hopman, and I.R. Zwijnenberg Chromosome instability in resection margins predicts recurrence of oral squamous cell carcinoma J Pathol 215 2008 347 348 (Pubitemid 351956716)
151. I.F. Tsui, C. Garnis, and C.F. Poh A dynamic oral cancer field: unraveling the underlying biology and its clinical implication Am J Surg Pathol 33 2009 1732 1738
152. R.P. Takes, A. Rinaldo, and C.E. Silver Future of the TNM classification and staging system in head and neck cancer Head Neck 32 2010 1693 1711
153. American Joint Committee for Cancer Staging and End-Results Reporting. Chicago: American Joint Committee on Cancer, 1998.
154. C.H. Chung, J.S. Parker, G. Karaca, J. Wu, W.K. Funkhouser, and D. Moore Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression Cancer Cell 5 2004 489 500 (Pubitemid 38610250)
155. E. Méndez, J.R. Houck, D.R. Doody, W. Fan, P. Lohavanichbutr, and T.C. Rue A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival Clin Cancer Res 15 2009 1353 1361
156. W.G. Hanson, and P.J. Ferguson Differential methotrexate toxicity between two human oral squamous carcinoma cell lines J Otolaryngol 22 1993 143 147 (Pubitemid 23233337)
157. W.W. Ma, and A.A. Adjei Novel agents on the horizon for cancer therapy CA Cancer J Clin 59 2009 111 137